ICD-10 Coding for Steroid-Induced Hyperglycemia(E09.9, E13.9, E11.9)
Complete ICD-10-CM coding and documentation guide for Steroid-Induced Hyperglycemia. Includes clinical validation requirements, documentation requirements, and coding pitfalls.
Also known as:
Related ICD-10 Code Ranges
Complete code families applicable to Steroid-Induced Hyperglycemia
E09-E13Primary Range
Diabetes mellitus due to underlying condition, drug or chemical induced, and other specified diabetes mellitus
This range includes codes for diabetes mellitus caused by drugs, such as steroids, and other specified types.
Adverse effect of glucocorticoids and synthetic analogues
This range is used to code the adverse effect of steroid use, which is necessary for complete coding of steroid-induced hyperglycemia.
Code Comparison: When to Use Each Code
Compare key differences between these codes to ensure accurate selection
| Code | Description | When to Use | Key Documentation |
|---|---|---|---|
| E09.9 | Drug or chemical induced diabetes mellitus without complications | Use when diabetes is induced by steroid use without prior diabetes history. |
|
| E13.9 | Other specified diabetes mellitus without complications | Use when diabetes is specified as other than type 1 or type 2 and not drug-induced. |
|
| E11.9 | Type 2 diabetes mellitus without complications | Use when pre-existing type 2 diabetes is exacerbated by steroid use. |
|
Clinical Decision Support
Always review the patient's clinical documentation thoroughly. When in doubt, choose the more specific code and ensure documentation supports it.
Key Information: ICD-10 code for steroid-induced hyperglycemia
Essential facts and insights about Steroid-Induced Hyperglycemia
Primary ICD-10-CM Codes for steroid induced hyperglycemia
Decision Criteria
clinical Criteria
- New-onset hyperglycemia temporally linked to steroid therapy
documentation Criteria
- Documentation must specify steroid use and lack of prior diabetes history
Clinical Validation Requirements
- Fasting glucose ≥126 mg/dL or random ≥200 mg/dL post-steroid
- HbA1c <6.5% before steroid initiation
Code-Specific Risks
- Misclassification as E11.9 or E13.9
Coding Notes
- Ensure documentation specifies the absence of prior diabetes and links hyperglycemia to steroid use.
E13.9 - Other specified diabetes mellitus without complications
Use when diabetes is specified as other than type 1 or type 2 and not drug-induced.
Applicable To
- Diabetes mellitus specified as other than type 1 or type 2
Excludes
- E09.9
- E11.9
Clinical Validation Requirements
- Fasting glucose ≥126 mg/dL or random ≥200 mg/dL
- No prior diabetes history
Coding Notes
Avoid using E13.9 for cases clearly linked to drug-induced diabetes.
E11.9 - Type 2 diabetes mellitus without complications
Use when pre-existing type 2 diabetes is exacerbated by steroid use.
Applicable To
- Type 2 diabetes mellitus
Excludes
- E09.9
- E13.9
Clinical Validation Requirements
- HbA1c ≥6.5% pre-steroid
- Worsening control post-steroid
Coding Notes
Ensure documentation specifies pre-existing type 2 diabetes and its exacerbation due to steroids.
Ancillary Codes
Additional codes that should be used in conjunction with the main diagnosis codes when applicable.
Differential Codes
Alternative codes to consider when ruling out similar conditions to the primary diagnosis.
Documentation & Coding Risks
Avoid these common documentation and coding issues when documenting Steroid-Induced Hyperglycemia to ensure proper reimbursement, maintain compliance, and reduce audit risk. These guidelines are particularly important when using ICD-10 code E09.9.
Impact
Clinical: Misdiagnosis of diabetes type., Regulatory: Non-compliance with coding standards., Financial: Potential reimbursement issues.
Mitigation Strategy
Educate clinicians on the importance of linking steroid use to hyperglycemia., Implement checklist for documenting drug-induced conditions.
Impact
Reimbursement: Incorrect DRG assignment may affect reimbursement., Compliance: Non-compliance with coding guidelines., Data Quality: Inaccurate clinical data and statistics.
Mitigation Strategy
Use E09.9 for drug-induced diabetes and ensure documentation specifies steroid use.
Impact
Reimbursement: Potential underpayment due to incomplete coding., Compliance: Failure to meet coding standards., Data Quality: Incomplete clinical data.
Mitigation Strategy
Always append Y42.7 for steroid causation when coding E11.9.
Impact
Risk of coding steroid-induced diabetes as type 2 diabetes without proper documentation.
Mitigation Strategy
Implement regular coding audits and clinician education.
Documentation errors, coding pitfalls, and audit risks are interconnected aspects of medical coding and billing. Addressing all three areas helps ensure accurate coding, optimal reimbursement, and regulatory compliance.
Frequently Asked Questions
Common questions about ICD-10 coding for Steroid-Induced Hyperglycemia, with expert answers to help guide accurate code selection and documentation.
Documentation Templates for Steroid-Induced Hyperglycemia
Use these documentation templates to ensure complete and accurate documentation for Steroid-Induced Hyperglycemia. These templates include all required elements for proper coding and billing.
Endocrinology Consult for Steroid-Induced Hyperglycemia
Specialty: EndocrinologyRequired Elements
- Patient history of steroid use
- Onset and duration of hyperglycemia
- Laboratory results (glucose, HbA1c)
- Treatment plan
Examples: Poor vs. Good Documentation
Poor Documentation Example
Good Documentation Example
Explanation
Need help with ICD-10 coding for Steroid-Induced Hyperglycemia? Ask your questions below.